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1. Introduction 
Femur length (FL) is the measurement between the distal and proximal ossification centers 
of the femoral diaphysis. FL is one of the fetal biometry measurements which is measured 
ordinarily during the routine second trimester scanning and onwards in determining the 
gestational age and growth between ultrasound examinations.  
 
Fig. 1. The scan showing  the correct FL measurement 
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Short FL is defined as below the 5th percentile or – 2 standard deviations (SD) appropriate 
for gestational age  at the ultrasound examination. FL measurement is one of the easiest fetal 
biometry measurements. However; careful ultrasonographic measurement of only the 
ossified portions of the diaphysis is needed to obtain accurate measurements. The ossified 
portion of the femur is measured from the major trochanter to the distal end of the femoral 
shaft; the distal and proximal epiphyses are not included in the measurement. Oblique 
planes must be avoided and the femur closer to the transducer must be measured while the 
transducer is aligned parallel to the long axis of the bone. (Figure 1) 
In most cases, short FL may be measured inaccurately or may be a variant of normal, 
especially if present as an isolated finding. However; short FL might be a diagnostic 
challenge for the examiner with various differential diagnoses. Short FL may be a part of a 
malformation such as a skeletal dysplasia or aneuploidies such as Trisomy 21 (Down 
Syndrome) or Monosomy X, and metabolic syndromes. (Kurtz et al.1990; Vergani et al. 2000; 
Bromley et al. 2002) Some studies have also suggested that a short FL is a feature of 
intrauterine growth restriction (IUGR) and small-for-gestational age (SGA) babies. (Todros 
et al. 1996; Zalel et al. 2002) Short FL may be associated with uteroplacental insufficiency 
and altered biochemical markers. (Weisz et al. 2008) 
In this chapter, the abnormalities that might present with a short FL will be described in 
detail and then the management of short FL will be discussed.  
2. Femur length and aneuplodies 
The antepartum detection of fetal aneuploidy is one of the major goals of prenatal screening 
programs and aneuploidies are the most common genetic abnormalities detected by 
prenatal diagnosis. (Nyberg et al. 2008) The major screening method for aneuploidies in the 
antenatal period is detection of abnormalities during ultrasonography in addition to 
biochemical markers, maternal age, and genetic risk. However, for definitive diagnosis, 
karyotype analysis by amniocentesis or chorionic villus biopsy is needed.  
Trisomy 21 (Down’s syndrome) is an aneuploidy characterized by presence of an extra 
chromosome 21. It is named after John Langdon Down who first described the syndrome in 
1866. (Down JLH; 1866)  The condition was identified as an extra chromosome 21 in 1959 by 
Jerome Lejeune. (Lejeune et al. 1959) Characteristic dysmorphic features of trisomy 21 
predominantly affect the head and neck and the extremities. Changes in the extremities 
include short broad hands, hypoplastic mid phalanx of fifth finger, incurved fifth finger, 
transverse palmar crease, space between the first and second toes (sandal gap deformity), 
hyperflexibility of joints. In addition, fetuses with trisomy 21 have slightly shorter long-
bones than their normal counterparts. Actually, the mean length at birth is approximately 
0.5 standard deviations (SD) less than normal babies in addition to decrease in birthweight 
and head circumference are less in babies with trisomy 21 when compared with normal 
counterparts. (Cronk CE; 1978) 
In 1987, Lockwood et al and Benacerraf et al were the first ones to show that short FL was 
associated with increased risk of trisomy 21. (Lockwood et al. 1987; Benacerraf et al. 1987) 
The other biometric parameters were also evaluated, but the most significant changes were 
observed in the length of the extremities. (Barr Jr M.; 1994) Various criteria have been 
described for the determination of short FL. Lockwood and Brumsfield used the biparietal 
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diameter (BPD) to FL ratio in order to evaluate the risk of Down syndrome. (Lockwood et al. 
1987; Brumsfield et al. 1989) Lockwood chose an upper limit of 1.5 standard deviations 
above the mean. This led to a sensitivity of 50% and false- positive rate of 7% for identifying 
fetuses with Down syndrome. Brumsfield suggested a sensitivity of 40% and false positive 
rate of 2.2% using a BPD: FL ratio of ≥ 1.8 in the second trimester. (Brumsfield et al. 1989) 
But, it must be kept in mind that the BPD: FL ratio might differ depending on the gestational 
age of the fetus; second trimester seems to be the best time for evaluation. On the other 
hand, Grist used the measured-to-expected FL ratio and identified fetuses with Down 
syndrome with a sensitivity of 50% and false positive rate of 6.5%. ( Grist et al. 1990) 
It seems that most of the studies suggest that fetuses with trisomy 21 have slightly short FL. 
However the change in FL is only slight and therefore it is regarded as a soft marker for 
trisomy 21. Soft markers of trisomy 21 are ultrasonographic findings with the possibility of 
association with chromosomal abnormalities such as choroid plexus cysts, echogenic bowel, 
short FL, short humerus length (HL), pyelectasis. They are insufficient to be used as an 
isolated marker, but rather they are more likely to be useful when combined with each 
other. (Bethune, 2007) It must be remembered that isolated soft markers are identified in 11-
17% of normal fetuses; however the prevalence is much higher in trisomy 21 and the risk of 
trisomy 21 increases more especially of there is more than one marker. (Breathnach et al., 2007) 
So a detailed fetal anatomy scanning should be performed to search for other markers when a 
short FL is encountered and if there is more than one marker a karyotype analysis should be 
obtained. Increased nuchal fold thickness, hypoplastic nasal bone and aberrant right 
subclavian artery are more powerful markers for Down Syndrome, and fetal chromosomal 
analysis might be offered in most cases with these findings even if they were isolated. 
Short HL is also associated with trisomy 21 and it is suggested that the risk of trisomy 21 is 
higher with a short HL than a short FL. (Bethune, 2007) Therefore measurement of HL 
should be part of the routine whenever a short FL is measured.  
Turner Syndrome (Monosomy X) is the only monosomy that is compatible with life. Turner 
syndrome was first described by Henry Turner in 1938 and was recognized to be secondary 
to karyotypic variation of 45,X in 1959. (Turner, 1938; Ford et al., 1959; Wiedemann & Glatzl, 
1991)  Although most conceptions with Turner syndrome die, 1% survive until term. 
(Cockwell et al., 1991) Its incidence is 1 in 2500 to 3000 live-born girls. Approximately half 
have monosomy X (45,X), and 5 to 10% have a duplication (isochromosome) of the long arm 
of one X (46,X,i(Xq)). (Sybert & McCauley, 2004) It is characterized by large cystic hygromata 
and fetal hydrops at the early stages of gestation in addition to short FL and short HL. (Chen & 
Chien, 2007) Live born fetuses may have minor problems such as short stature, widely spaced 
nipples, congenital lymphedema, webbed neck, and minor bone and cartilage abnormalities. 
Prenatal sonographic diagnosis is usually established in the late first and early second 
trimesters, secondary to cystic hygroma formation. (Weisz et al., 2008) One study evaluated 
the clustered ultrasonography findings in fetuses with Turner syndrome. (FitzSimmons et al., 
1994) Thirteen fetuses with Turner syndrome were observed among 9348 early pregnancies 
(1/3086). Huge septated cystic hygroma, subcutaneous edema, and hydrops were observed in 
all cases. Short FL was detected in 12 of the 13 (92%) fetuses. Papp et al reported seven fetuses 
(10.1%) with short FL in 69 fetuses with Turner syndrome. The authors concluded that the 
addition of the soft marker of short FL to the second-trimester sonographic survey may 
increase the detection rate of Turner syndrome. (Papp et al.,2006) 
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Todros et al evaluated the outcome of pregnancy in 86 fetuses diagnosed with short FL in 
the second trimester ultrasonography scanning. (Todros et al., 2004) Twenty-eight of the 
fetuses (32.5%) were normal, 40 (46.5%) were structurally abnormal and 18 (21%) were small 
for gestational age. Of the 40 malformed fetuses, 16 (40%) were aneuploid. The structural 
malformations associated with aneuploidy included 10 cases of congenital heart disease 
with trisomy 21, three cases of multiple malformations with trisomy 18, one case of multiple 
malformations with trisomy 13 and two cases of Turner syndrome with aortic coarctation. 
None of the fetuses with isolated short FL was aneuploid. Therefore the authors suggested 
that short FL is not considered as an indication for karyotype analysis unless associated with 
other sonographic markers.  
3. Femur length, skeletal dysplasias and other malformations 
The skeletal dysplasias account for about 5% of the genetic disorders seen in the newborn 
period. (Orioli et al.,1986) They represent a significant burden to many families because of 
potential lethality, and short- and long-term medical complications, and recurrence risk. The 
fetal skeleton is easily visualized by ultrasound, however most series note a diagnostic 
accuracy for the skeletal dysplasias at less than 50%. (Doray et al., 2000; Parilla et al., 2003; 
Krakow et al., 2008) 
Shortening of the FL is referred to as rhizomelia. When a short FL is identified before 24 
weeks gestation, skeletal dysplasias must be considered and all long bones (each femur, 
humerus, radius, ulna, tibia, and fibula) must be measured to determine the relative length 
against normal values. In addition to measurement of the length, the long bones should be 
evaluated regarding changes in shape, mineralization, bowing, angulation, and metaphyseal 
flare. Although there is severe shortening of all limbs in the majority of skeletal dysplasias, 
the foot length is relatively normal. The normal FL: foot length ratio is 1.0 throughout the 
pregnancy, thus a ratio of less than 1 is useful in distinguishing skeletal dysplasia from other 
causes of short FL, such as IUGR or aneuploidy. (Campbell et al., 32)  
Many skeletal dysplasias and specific syndromes are associated with short FL. These are 
listed in Table 1; however in most of these, it is possible to detect several additional 
ultrasonographic markers in a detailed ultrasonography scan.  
Achondroplasia (OMIM Entry # 100800) is the most frequent form of short-limb dwarfism 
and most common form of skeletal dysplasia. (Horton et al., 2007) It occurs in one in 15,000 
to one in 40,000 live births. 
It is caused by mutation in the fibroblast growth factor receptor-3 gene (FGFR3), which is 
located at chromosome 4p16.3 and is inherited as an autosomal dominant fashion with 
essentially complete penetrance. (Superti-Furga & Unger, 2007) More than 99% of individuals 
with achondroplasia have one of two mutations in FGFR3. Over 80% of individuals with 
achondroplasia have parents with normal stature and have achondroplasia as the result of a de 
novo gene mutation. Affected individuals exhibit short stature caused by rhizomelic shortening 
of the limbs, characteristic face with frontal bossing and midface hypoplasia, exaggerated 
lumbar lordosis, limitation of elbow extension, bowed legs, and trident hand. (Nyberg, 2003) 
Head and abdominal circumference may be normal, but are often enlarged. But these signs are 
not specific. Prenatal sonographic diagnosis is often not possible as the length of long bones is 
well  preserved until around 22 weeks’ gestation, the time of the routine fetal anomaly scan. 
(Goncalves & Jeanty, 1994; Chitty et al., 2011)  The FL is at the fifth percentile at this time and 
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then below the first percentile at about 30 weeks. (Nyberg, 2003) Presentation and diagnosis of 
de novo cases often occurs at this period when the short limbs, frontal bossing and trident hand 
may be evident. Even then, misdiagnosis is common. (Modaff et al., 1996)  
 
 
Table 1. The list of skeletal dysplasias  and syndromes  that might present prenatally with 
isolated short FL 
Bowing of the femora have been reported in some cases. One study suggested that all the 
fetuses with achondroplasia had rounded metaphyseal–epiphyseal interface, with an angle 
connexion to diaphysis wider than expected at the ultrasonography scan. (Boulet et al., 2009) 
Routine prenatal ultrasound examination may identify short FL and raise the possibility of 
achondroplasia in a fetus not known to be at increased risk. Krakow et al described the use 
of 3D ultrasonography in pregnancies from 16 to 28 weeks' gestation to enhance 
appreciation of the facial features and relative proportions of the appendicular skeleton and 
limbs for the diagnosis of achondroplasia. (Krakow et al., 2009) Ruano et al used a 
combination of 3D ultrasonography and intrauterine 3D helical computer tomography to 
enhance the diagnostic accuracy for intrauterine skeletal dysplasias. (Ruano et al., 2004) 
Molecular testing can confirm the diagnosis in achondroplasia. DNA extracted from fetal 
cells obtained by amniocentesis or fetal cord blood sampling can be analyzed for FGFR3 
mutations if achondroplasia is suspected. (Francomano et al., 1993a) 
Alkyldihydroxacetonephosphate synthase deficiency 
Atelosteogenesis type III 
Barrow (1984)- short-limbed dwarfism; congenital heart defect 
Baxova (1993)- micromelic bone dysplasia-humerus, femur, tibia type 
Brachydactyl-type A1 
Chondrodysplasia punctata-tibia metacarpal type 
De la Chapelle-neonatal osseous dysplasia 
Dysspondylochondromatosis 
Gracile bone dysplasia 
Hypochondroplasia 
Hypochondroplasia (autosomal recessive) 
Kyphomelic dysplasia 
Metaphyseal acroscyphodysplasia 
Metaphyseal chondrodysplasia- cone-shaped epiphyses 
Omodysplasia 
Omodysplasia type II 
Patterson (1975)-rhizomelic dysplasia 
Proximal femoral focal deficiency 
Pseudoacondroplasia-like syndrome 
Slaney (1999)- spondyloepimetaphyseal dysplasia-hypogammaglobulinaemia 
Spondyloepimetaphyseal dysplasia-type Genevieve 
Spondylometaphyseal dysplasia-type Borochowitz 
Spondylometaphyseal dysplasia-type Sutcliffe 
Silver-Russell syndrome 
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Hypochondroplasia (OMIM Entry #146000) is also inherited in an autosomal dominant pattern 
and caused by mutation in the gene for FGFR3 located on 4p, which is 98-99% mutated in 
achondroplasia. (Francomano et al., 1993b) The majority of the cases result from 
spontaneous mutations and that the unaffected parents of a child with hypochondroplasia 
have an extremely low risk (<0.01%) of having another affected child. Its prevalence is 1 in 
50.000 births. (Hicks, 2003) The molecular testing strategies can detect only % 70 of the cases. 
Not all patients with presumed hypochondroplasia have demonstrable mutations in the 
FGFR3 gene, suggesting genetic heterogeneity. It is characterized by short stature, short 
arms and legs, and macrocephaly. The skeletal features are very similar to achondroplasia 
but usually tend to be milder. (Spranger, 1988) Shortening of long bones with mild 
metaphyseal flare is observed. The hands are relatively short but do not exhibit the "trident" 
appearance that is typical in achondroplasia. Facial features are usually normal and the 
classic facial features of achondroplasia (e.g., midface hypoplasia, frontal bossing) are not 
generally seen. Head size may be large without significant disproportion.  
Hypochondroplasia shows some resemblance to achondroplasia, but is much milder and 
can be distinguished on clinical and radiographic grounds. Unlike achondroplasia, motor 
milestones are usually not significantly delayed and symptoms resulting from spinal cord 
compression (e.g., apnea, neuropathy) are less common. (Wyne-Davies et al., 1981) 
The antenatal  diagnosis is difficult  as skeletal disproportion tends to be mild and the 
ultrasonography findings nonspecific. Prenatal molecular genetic testing is available if the 
mutations in the parents with hypochondroplasia have been identified. If the mutation causing 
hypochondroplasia cannot be identified, ultrasound examination is the only method of prenatal 
testing. It is often possible to detect an affected fetus early in the pregnancy if the fetus is at risk 
of being a heterozygote with another dominantly inherited skeletal dysplasia. (Francomano et 
al., 1993b) However, it is currently difficult to detect heterozygous hypochondroplasia or other 
milder phenotypes using ultrasonography. Signs of disproportionate growth may suggest the 
diagnosis of hypochondroplasia, but a "normal" third trimester ultrasound examination is not 
sufficient to rule out a diagnosis of hypochondroplasia. DNA banking may be offered to the 
family for future analysis. DNA-based diagnosis (FGFR3 N540K and G380R mutation analysis) 
via chorion villus sampling, amniocentesis or fetal cord blood sampling  may be helpful in 
ruling out lethal forms of skeletal dysplasia and establishing a more favorable prognosis for the 
fetus. (Francomano et al., 1993b)  
Leroy I-cell disease is an autosomal recessive disorder first described in 1967 by Leroy and 
Demars and called I-cell disease due to the presence of phase dense intracytoplasmic 
inclusions in fibroblasts which were termed I cells. (Leroy et al., 1969) There is a biochemical 
defect in uridine diphospho-N-acetylglucosamine-1-phosphotransferase, which is the 
enzyme that catalyses addition of a mannose phosphate residue for lysosomal trafficking. 
(Wenger et al., 2002) Death from pneumonia or congestive heart failure usually occurs 
within the first decade of life. The most severely affected system is the skeletal system. Bone 
changes are similar to those observed in mucopolysaccharidoses. The classic finding is 
dysostosis multiplex, with a cloaking appearance of the long tubular bones due to periosteal 
new bone formation, anterior beaking and wedging of the vertebral bodies, widening of the 
ribs, proximal pointing of the metacarpals, and bullet shaped phalanges. Other findings are 
coarse facial features, developmental delay, growth failure, umbilical and inguinal hernias, 
hepatomegaly, and hypotonia. (Benacerraf, 1998)  Lees et al have described polyhydramnios 
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and short femurs in a case of Leroy I-cell disease that was diagnosed in the postnatal period. 
(Lees et al., 2001) The family had a history of Leroy I-cell disease. Yuksel et al reported two 
cases that both had short femurs and in one femoral bowing was additionally detected in 
the late second trimester and both were diagnosed as Leroy I-cell disease by enzyme 
analysis in the postnatal period. (Yuksel et al., 2007) None of the two families had a history 
of Leroy I-cell disease. Invasive prenatal diagnosis is possible by analysis of enzyme activity 
in chorionic villi or cultured amniocytes, but it is offered to families only known to be at risk 
for  the metabolic disease. 
For most of the other skeletal dysplasias presenting with short FL, other associated 
ultrasound findings such as bell-shaped thorax, protuberant abdomen, and polydactyl are 
present. (Nyberg, 2003) 
Femoral-facial syndrome (FFS), also known as femoral hypoplasia-unusual facies syndrome 
(FHUFS) (MIM 134780), first described by Daentl et al, is a rare and sporadic multiple 
congenital anomaly syndrome comprising bilateral femoral hypoplasia and characteristic 
facial features, such as long philtrum, thin upper lip, micrognathia with or without cleft 
palate, and a short nose with broad tip. (Daentl et al., 1975; Nowaczyk et al., 2003)  
Nowaczyk et al reported an infant born with the disorder whose ultrasonography scan  at 19 
weeks was reported as normal. Review of the prenatal radiographs showed no diagnostic 
features in this child. These authors underlined the difficulties in identifying femoral 
abnormalities on 2D imaging and suggested that 3D imaging would be more effective for 
prenatal diagnosis. (Nowaczyk et al., 2003) 
Acampomelic campomelic dysplasia (MIM 114290) is referred to cases without campomelia 
which is the bowing of the legs, especially the tibias. (Macpherson et al., 1989) However the 
other features of the syndrome such as ovarian dysgenesis, craniofacial changes, and 
defective tracheal bronchial cartilage are observed. (Rodriguez, 1993) Mutations in SOX-9 
gene have been observed, 46, XY sex reversal is common. (Kwok et al., 1995) 
Shprintzen syndrome (MIM 182212) is also associated with short FL. It is characterized by 
short stature, mild mental retardation, ear and hearing abnormalities, microcephaly, 
micrognathia, and cardiac and limb defects. The syndrome is autosomal dominantly  
inherited and is  caused by mutations in the fibrillin 1 gene, which cannot be tested easily in 
the antenatal period due to its size. (Biery et al., 1999) 
The most important point in the antenatal diagnosis of skeletal dysplasias is the prediction 
of lethal disorders. It is crucial to measure the thoracic circumference and warn the parents 
when the thoracic circumference is well below the fifth centile. Multidisciplinary approach 
is necessary in the diagnosis and counselling of these cases. After delivery or termination of 
the pregnancy, the diagnosis should be confirmed by clinical, radiographic, and 
histopathological analysis and also by molecular testing strategies when available. Cell 
cultures  and DNA should be banked to be used for future diagnostic  molecular testing.  
4. Femur length and intrauterine growth restriction 
Several case series have shown an association between short FL and  IUGR. Bromley et al, 
reported four fetuses with  short femurs  measuring more than 2 SD below the mean 
compared with the biparietal diameter. (Bromley et al., 1993) These fetuses were 
subsequently found to have severe IUGR with no evidence of skeletal dysplasia. Two other 
studies have described a short FL in cases with  IUGR. (O’Brien et al., 1982)  
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In one study, 18 of the 86 fetuses (21%) referred for FL below the 10th percentile had SGA. 
(Todros et al., 2004) The diagnosis of SGA in fetuses was confirmed about 9 weeks after the 
initial finding of short FL. In another study short FL was associated with low birth weight 
and SGA, but not with gestational hypertension. These cases of isolated short FL were 
associated with significantly lower levels of pregnancy associated plasma protein- A (PAPP-
A), but similar β-hCG, inhibin-A, and alpha-fetoprotein (AFP) when compared to fetuses 
with normal FL. (Qin et al., 2006)  
Fetuses with short FL at the second trimester scanning might be considered as having an 
increased risk of IUGR. Maternal evaluation regarding blood pressure monitorization and 
follow-up for development of preeclampsia, ultrasonographic evaluation of the placenta, and 
Doppler analysis should be offered in this situation. In one study 50% of the women developed 
preeclampsia while undergoing follow-up for short FL and IUGR. (Todros et al., 2004)   
The association between short FL and IUGR is unclear. It might be explained by the brain 
sparing effect with decreased flow to the lower body. It is likely that IUGR and short FL are 
linked to preeclampsia by the common mechanism of placental insufficiency. (Weisz et al., 2008)  
Silver-Russell syndrome (SRS, MIM 180860) is a syndrome characterized by severe 
asymmetric IUGR, poor postnatal growth, craniofacial features such as a triangular shaped 
face and a broad forehead, body asymmetry, and a variety of minor malformations. It was 
reported independently by Silver et al. and Russell. (Silver et al., 1953; Russell, 1954) The 
long bones are short whereas the head measurements are within the normal range. The 
hallmark for the diagnosis of Silver-Russell  syndrome is the demonstration of limb length 
asymmetry, which is unusual in other conditions. Yet there is no specific testing to confirm 
the diagnosis in the prenatal period. (Nyberg, 2003) In very near future testing strategies like 
chip-based next generation sequencing and methylation testing assays will be available for 
definitive diagnosis of SRS cases and many other sydromes having  short femurs  as the  
only clinical sign will be thoroughly evaluated during the antenatal period.  
5. Femur length and normal variants 
It must be considered that most of the fetuses presenting with isolated short FL are clinically  
normal. A short FL is defined as below the 5th percentile or below two standard deviations 
from the mean for the gestational age. That results in a pickup rate that exceeds the expected 
frequency of skeletal dysplasias. Various criteria have been published for the determination 
of short FL and HL. (Lockwood et al., 1987; Benacerraf et al., 1992) These criteria overlap the 
range observed in unaffected fetuses and vary widely among different populations; 
therefore, it would be prudent to develop standards for each population. Some authors have 
advocated the use of ethnic-specific FL growth charts. FL is observed to be shorter in Asian 
and oriental populations. (Nyberg, 2003; Down, 1866; Bromley et al., 1993; Shipp et al., 2001; 
Kovac et al., 2002a; Drooger et al., 2005)  A significant difference in the mean expected FL 
among fetuses in the second trimester with regard to ethnicity was observed. It was stated 
that using ethnic-specific formulas for expected FL can have a considerable impact on the 
use of sonographic risk factors for trisomy 21 screening. (Kovac et al., 2002b) In another 
study, it was reported that short stature increased a woman's risk of having an abnormal 
BPD:FL ratio at the second trimester. They indicated that risk assessment for fetal trisomy 21 
for such patients might be inaccurate. (Drooger et al., 2005) At 18 and 19 weeks' gestation, 
women shorter than one SD below the mean were twice as likely to have an abnormal BPD: 
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FL ratio compared with women taller than one SD above the mean (relative risk 2.38; 95% 
confidence interval 1.21, 4.69). (Drooger et al., 2005) 
6. Management of short femur length 
The differential diagnoses of short FL include normal variation, a false-positive 
measurement, IUGR, aneuploidy, and skeletal dysplasias. Very short FL is suggestive for 
skeletal dysplasias and other syndromes. (Table 2) 
 
Diagnosis Down 
Syndrome 
Achondroplasia Skeletal 
Dysplasias/Syndromes 
Intrauterine
Growth 
Restriction
Constitutional 
Detailed 
anomaly 
scan 
Markers of 
aneuploidy 
(echogenic 
intracardiac 
focus, 
pyelectasis, 
choroid 
plexus cysts, 
duodenal 
atresia, 
nuchal 
translucency
, etc) 
Frontal bossing, 
short fingers, 
trident hand  
short  arms, 
narrow chest, 
macrocephaly 
Abnormalities of other 
tubular bones, bowing, 
metaphyseal changes, 
abnormal 
posture/movements, 
thoracic circumference 
important 
Small 
biometric 
measureme
nts, 
possible 
abnormal 
Doppler 
findings 
No obvious 
changes 
Femur 
growth 
pattern 
Often about 
5th centile 
from early 
pregnancy 
on 
Normal until 25 
weeks, then 
falls in centiles 
Severely short at  second 
trimester or before  
Variable 
onset, 
might 
begin with 
short FL 
weeks 
before 
small 
abdominal 
circumfe-
rence 
Often near 5th 
percentile, 
growth 
velocity is 
normal 
Diagnosis Down 
syndrome 
screening 
tests, 
karyotype 
analysis if > 
1 soft marker
Molecular 
testing (Family 
history may be 
positive, de novo 
mutations 
common) 
Depends on diagnosis and 
inheritance pattern. 
Postnatal diagnosis is 
possible. . Cell culture and 
DNA banking must be 
offered.  
Karyotype 
analysis if 
> 1 soft 
marker, 
growth 
restriction 
develops 
during 
follow-up 
Mother 
and/or father 
has short 
stature. 
History of 
short stature 
Table 2. Differential Diagnosis of short femur length 
Detailed ultrasonography scanning should be performed in patients presenting with short FL 
to exclude fetal malformations. Other tubular bones should be evaluated in addition to FL.  
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It must be remembered that the majority of isolated short FL are normal or constitutionally 
short and 13-61% of the fetuses diagnosed with isolated short FL at the second trimester 
scanning are classified as normal eventually on the follow-up. (Todros et al., 2004; 
Papageorghiou et al., 2008) In contrast, severely shortened (<5th percentile) or abnormal 
appearing long bones may be a sign of a skeletal dysplasia or early onset fetal growth 
restriction. (Weisz et al., 2008) 
Counselling should be given to cases with isolated short FL; however a more conservative 
approach is more appropriate. Serial ultrasonography examinations should be performed in 
order to exclude skeletal dysplasias, IUGR, and uteroplacental insufficieny. Karyotype 
analysis should be offered if there are other sonographic markers suggesting aneuploidies. 
In cases where the karyotype analysis is normal, it is wise to store the DNA for future 
analysis in cases of sporadic skeletal dysplasias and syndromes. Isolated short FL cases  
should be followed up. Short FL due to IUGR should be suspected if during follow-up a 
small abdominal circumference, or abnormal Doppler parameters develop. If the FL falls 
further from the mean in the three-four weeks of follow-up skeletal dysplasia or severe 
IUGR should be suspected. (Kurtz et al., 1990) 
Mild shortening of FL may suggest chromosomal abnormality or a syndrome. (Benacerraf et 
al., 1987; LaFollette et al., 1989; Perella et al., 1988; Nyberg et al., 1990)  If mildly short FL 
(defined as length < 90% of the predicted FL) is present, there is a 1% risk of trisomy 21 in a 
high risk population (1/250 trisomy 21) and 3% risk of trisomy 21 in a low risk population 
(1/700 trisomy 21). (Nyberg et al., 1990) Short HL is even more specific than short FL in 
predicting trisomy 21. If short HL (defined as length < 90% of the predicted HL) is 
identified, there is a 3% risk of trisomy 21 in a high-risk population and a 1-2% risk of 
trisomy 21 in a low-risk population. (Benacerraf et al., 2001) 
In the third trimester, one should remember that the FL is subject to the same ‘biologic 
variability’ as other biometric markers. It is not unusual for the FL measurement to be 
slightly less than other biometric markers in the absence of morphologic abnormality. This is 
particularly true if the remainder of the sonographic evaluation of the fetus is normal.  
Evaluation of fetal posture and fetal movements are very important in prenatal ultrasound. 
Abnormal posture or movement may be the first clues to either focal or generalized 
musculoskeletal abnormality. Some skeletal dysplasias may develop additional features 
during the follow-up. The family must be clarified about the fact that some of the sydromes 
cannot be ruled out despite detailed sonographic evaluation.  
7. Key points 
1. Most of the fetuses with isolated short FL are normal or constitutionally short. 
2. Detailed sonographic evaluation regarding additional markers for aneuploidy, 
measurement of other tubular bones, Doppler analysis should be performed. 
3. If there are additional markers, karyotype analysis should be performed. The DNA may 
be banked for future analysis.  
4. If the fetal karyotype analysis is normal, serial follow-up scans should be scheduled. 
5. If, during follow-up the FL falls more from the mean, skeletal dysplasias or severe 
IUGR should be suspected. Molecular analysis must be performed  for the diagnosis of 
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skeletal dysplasias with known molecular teiology, such as achondroplasia and 
hypochondroplasia . Preeclampsia must be ruled out.  
6. Findings more suggestive for skeletal dysplasias include FL 2 SD below the mean for 
gestational age; FL/ foot length <1; and FL/ abdominal circumference < 0.16 . 
7. Despite detailed sonographic evaluation, some of the syndromes cannot be ruled out 
and postnatal clinical genetic  evaluation of fetuses or newborns should be considered.  
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